Expression of α-taxilin in hepatocellular carcinoma correlates with growth activity and malignant potential of the tumor

International Journal of Oncology

Volumn 37, Issue 6, 2010, Pages 1417-1423

  Ohtomo, Natsuko ^a   Tomiya, Tomoaki ^a   Tanoue, Yasushi ^a   Inoue, Yukiko ^a   Nishikawa, Takako ^a   Ikeda, Hitoshi ^b   Seyama, Yasuji ^a   Kokudo, Norihiro ^a   Shibahara, Junji ^a   Fukayama, Masashi ^a   Koike, Kazuhiko ^a   Shirataki, Hiromichi ^c   Fujiwara, Kenji ^d  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^c DOKKYO MEDICAL UNIVERSITY   (Japan)

^d YOKOHAMA ROSAI HOSPITAL   (Japan)

Author keywords

Hepatocellular carcinoma; Taxilin; Vesicular transport proteins

Indexed keywords

ALPHA TAXILIN; CYCLINE; MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

AGED; ARTICLE; CANCER GROWTH; CELL PROLIFERATION; CLINICAL ARTICLE; FEMALE; HEPATOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MALE; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AGED; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; HEP G2 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; TUMOR MARKERS, BIOLOGICAL; VESICULAR TRANSPORT PROTEINS;

EID: 78649976013     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo-00000793     Document Type: Article

References (37)

1. Pang RW and Poon RT: From molecular biology to targeted therapies for hepatocellular carcinoma: the future is now. Oncology 72 (Suppl. 1): 30-44, 2007. (Pubitemid 350256663)
2. Trevisani F, Cantarini MC, Wands JR and Bernardi M: Recent advances in the natural history of hepatocellular carcinoma. Carcinogenesis 29: 1299-1305, 2008.
3. Stromberg S, Agnarsdottir M, Magnusson K, et al: Selective expression of Syntaxin-7 protein in benign melanocytes and malignant melanoma. J Proteome Res 8: 1639-1646, 2009.
4. Hashimoto S, Onodera Y, Hashimoto A, et al: Requirement for Arf6 in breast cancer invasive activities. Proc Natl Acad Sci USA 101: 6647-6652, 2004. (Pubitemid 38586028)
5. Bascom JL, Fata JE, Hirai Y, Sternlicht MD and Bissell MJ: Epimorphin overexpression in the mouse mammary gland promotes alveolar hyperplasia and mammary adenocarcinoma. Cancer Res 65: 8617-8621, 2005.
6. Rothman JE: Mechanisms of intracellular protein transport. Nature 372: 55-63, 1994.
7. Chen YA and Scheller RH: SNARE-mediated membrane fusion. Nat Rev Mol Cell Biol 2: 98-106, 2001.
8. 2+-dependent exocytosis in neuroendocrine cells. Genes Cells 8: 17-28, 2003.
9. Oba-Shinjo SM, Bengtson MH, Winnischofer SM, et al: Identification of novel differentially expressed genes in human astrocytomas by cDNA representational difference analysis. Brain Res Mol Brain Res 140: 25-33, 2005.
10. Sakakibara S, Nakadate K, Tanaka-Nakadate S, et al: Developmental and spatial expression pattern of alpha-taxilin in the rat central nervous system. J Comp Neurol 511: 65-80, 2008.
11. The Liver Cancer Study Group of Japan: The general rules for the clinical and pathological study of primary liver cancer. Kanehara & Co., Ltd., Tokyo, 2008.
12. Yoshida K, Nogami S, Satoh S, et al: Interaction of the taxilin family with the nascent polypeptide-associated complex that is involved in the transcriptional and translational processes. Genes Cells 10: 465-476, 2005.
13. Kitamoto M, Nakanishi T, Kira S, et al: The assessment of proliferating cell nuclear antigen immunohistochemical staining in small hepatocellular carcinoma and its relationship to histologic characteristics and prognosis. Cancer 72: 1859-1865, 1993.
14. Zeng WJ, Liu GY, Xu J, Zhou XD, Zhang YE and Zhang N: Pathological characteristics, PCNA labeling index and DNA index in prognostic evaluation of patients with moderately differentiated hepatocellular carcinoma. World J Gastroenterol 8: 1040-1044, 2002.
15. Yang L, Yang XC, Yang JK, et al: Cyclosporin A suppresses proliferation of endothelial progenitor cells: involvement of nitric oxide synthase inhibition. Intern Med 47: 1457-1464, 2008.
16. Bravo R, Frank R, Blundell PA and Macdonald-Bravo H: Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta. Nature 326: 515-517, 1987.
17. Ng IO, Lai EC, Fan ST, Ng M, Chan AS and So MK: Prognostic significance of proliferating cell nuclear antigen expression in hepatocellular carcinoma. Cancer 73: 2268-2274, 1994.
18. Suehiro T, Matsumata T, Itasaka H, Yamamoto K, Kawahara N and Sugimachi K: Clinicopathologic features and prognosis of resected hepatocellular carcinomas of varied sizes with special reference to proliferating cell nuclear antigen. Cancer 76: 399-405, 1995.
19. Taniai M, Tomimatsu M, Okuda H, Saito A and Obata H: Immunohistochemical detection of proliferating cell nuclear antigen in hepatocellular carcinoma: relationship to histological grade. J Gastroenterol Hepatol 8: 420-425, 1993.
20. Yun JP, Miao J, Chen GG, et al: Increased expression of nucleophosmin/B23 in hepatocellular carcinoma and correlation with clinicopathological parameters. Br J Cancer 96: 477-484, 2007.
21. Kosuge T, Makuuchi M, Takayama T, Yamamoto J, Shimada K and Yamasaki S: Long-term results after resection of hepatocellular carcinoma: experience of 480 cases. Hepatogastroenterology 40: 328-332, 1993.
22. Aoki T, Inoue S, Imamura H, et al: EBAG9/RCAS1 expression in hepatocellular carcinoma: correlation with tumour dedifferentiation and proliferation. Eur J Cancer 39: 1552-1561, 2003.
23. Yamamoto S, Tomita Y, Nakamori S, et al: Elevated expression of valosin-containing protein (p97) in hepatocellular carcinoma is correlated with increased incidence of tumor recurrence. J Clin Oncol 21: 447-452, 2003.
24. Yamaguchi R, Yano H, Nakashima O, et al: Expression of vascular endothelial growth factor-C in human hepatocellular carcinoma. J Gastroenterol Hepatol 21: 152-160, 2006.
25. Harada K, Yasoshima M, Ozaki S, Sanzen T and Nakamura Y: PCR and in situ hybridization studies of telomerase subunits in human non-neoplastic livers. J Pathol 193: 210-217, 2001.
26. Nogami S, Satoh S, Tanaka-Nakadate S, et al: Identification and characterization of taxilin isoforms. Biochem Biophys Res Commun 319: 936-943, 2004.
27. Nishizawa M, Kataoka K, Goto N, Fujiwara KT and Kawai S: v-maf, a viral oncogene that encodes a 'leucine zipper' motif. Proc Natl Acad Sci USA 86: 7711-7715, 1989.
28. Cai H, Reinisch K and Ferro-Novick S: Coats, tethers, Rabs, and SNAREs work together to mediate the intracellular destination of a transport vesicle. Dev Cell 12: 671-682, 2007.
29. Jantsch-Plunger V and Glotzer M: Depletion of syntaxins in the early Caenorhabditis elegans embryo reveals a role for membrane fusion events in cytokinesis. Curr Biol 9: 738-745, 1999.
30. Low SH, Li X, Miura M, Kudo N, Quinones B and Weimbs T: Syntaxin 2 and endobrevin are required for the terminal step of cytokinesis in mammalian cells. Dev Cell 4: 753-759, 2003.
31. Prekeris R and Gould GW: Breaking up is hard to do - membrane traffic in cytokinesis. J Cell Sci 121: 1569-1576, 2008.
32. Rospert S, Dubaquie Y and Gautschi M: Nascent-polypeptide-associated complex. Cell Mol Life Sci 59: 1632-1639, 2002.
33. Hirose H, Arasaki K, Dohmae N, et al: Implication of ZW10 in membrane trafficking between the endoplasmic reticulum and Golgi. EMBO J 23: 1267-1278, 2004.
34. Karess R: Rod-Zw10-Zwilch: a key player in the spindle checkpoint. Trends Cell Biol 15: 386-392, 2005.
35. Chen CS, Nelson CM, Khauv D, et al: Homology with vesicle fusion mediator syntaxin-1a predicts determinants of epimorphin/syntaxin-2 function in mammary epithelial morphogenesis. J Biol Chem 284: 6877-6884, 2009.
36. Miura K, Yoshino R, Hirai Y, et al: Epimorphin, a morphogenic protein, induces proteases in rodent hepatocytes through NF-kappaB. J Hepatol 47: 834-843, 2007.
37. Grabowski P, Schonfelder J, Ahnert-Hilger G, et al: Expression of neuroendocrine markers: a signature of human undifferentiated carcinoma of the colon and rectum. Virchows Arch 441: 256-263, 2002.